
A leaflet for parents and carers about the use of methylphenidate (brand names: Ritalin, Rubifen) for attention deficit hyperactivity disorder (ADHD).
Treatment with medicines is part of a comprehensive treatment programme for ADHD that includes behavioural therapy. The diagnosis of ADHD must have been confirmed by a specialist.
The leaflet is an adaptation of 'Medicines for children: Information for parents and carers' at Medicines For Children UKarrow_outward
The adaptation is by the New Zealand Formulary for Childrenarrow_outward
Leaflets on the New Formulary for Children website are only available to users in New Zealand and its territories.